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Background: Many veterans engaged in care with the Veterans Administration (VA) health system are also enrolled
in Medicare and/or Medicaid and may receive care both inside and outside of the VA. Use of dual health systems
has been associated with worse outcomes. Veterans with HIV may have different rates of Medicare and Medicaid
enrollment and may be at greater risk of poor outcomes related to non-VA use. This study compares the frequency
and factors associated with Medicare and/or Medicaid enrollment and non-VA use in an HIV-infected and uninfected
population of veterans.
Methods: We used data from the VA and Center for Medicare & Medicaid Services from 2004 and 2005 to determine
the frequency of Medicare and/or Medicaid enrollment among a cohort of HIV-infected and uninfected veterans
engaged in VA care. We then restricted the cohort to veterans enrolled in fee-for-service (FFS) Medicare and/or
Medicaid with at least one hospitalization and identified characteristics associated with non-VA hospital admissions.
Results: HIV-infected veterans had higher rates of Medicare and/or Medicaid enrollment than uninfected veterans
(38% vs. 33%, p < 0.01), though the opposite was true when our sample was limited to veterans 65 years and older
(53% vs. 70%, p < 0.0 1). Among veterans enrolled in the VA and FFS Medicare and/or Medicaid, veterans with HIV had
greater illness severity and more frequent hospitalizations, but were less likely to be hospitalized outside the VA (48%
vs. 54%, p < 0.01). HIV infection was associated with lower odds of outside hospitalization (OR = 0.76 [95% CI: 0.68,
0.85]).
Conclusions: Veterans with HIV have higher rates of Medicare and/or Medicaid enrollment, but lower odds of non-VA
hospitalization. The VA integrated model of HIV care may discourage outside use among HIV-infected veterans.
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A significant proportion of veterans enrolled with the
Veterans Administration (VA) healthcare system are also
enrolled in Medicare and/or Medicaid (“CMS enrollment”).
An expansion of Medicaid coverage under the Patient Pro-
tection and Affordable Care Act of 2010 (ACA) will likely
increase the proportion of CMS enrolled veterans [1]. Use* Correspondence: Harry.Chang@yale.edu
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unless otherwise stated.of non-VA health care (“CMS use”) among veterans already
engaged in VA care can lead to fragmented, inefficient,
lower quality care and increased mortality [2-6].
Previous work has described CMS enrollment and
identified factors that influence CMS use among VA en-
rolled veterans, particularly veterans 65 years and older
that have age qualified for Medicare [7-9]. Less is known
about CMS use among veterans under 65 years of age,
who may qualify for Medicare through disability, or
those enrolled in Medicaid. People living with HIV are
more likely to qualify for Medicare through disability
than age, and Medicare currently provides coverage forThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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in the U.S. [10]. Medicaid coverage for HIV varies on a
state-to-state basis, but it currently covers about 50% of
the people receiving HIV care in the U.S. [11]. Little is
known about CMS enrollment among HIV-infected vet-
erans, and the frequency and drivers of CMS use among
veterans with both VA and CMS coverage.
HIV-infected veterans are an aging cohort vulnerable to
adverse outcomes because of the complexity of their care
needs, including multimorbidity, polypharmacy, mental
health issues, and substance use [12-14]. The VA is the
largest provider of care for persons with HIV in the
United States, with over 20,000 veterans in care, and
has invested significant resources to create an inte-
grated HIV care model [15,16]. The integrated model
for HIV care in VA emphasizes case management and
access to coordinated medical and behavioral health
care services, including mental health care, urgent care,
substance abuse and on-site pharmacy services. Previ-
ous research has demonstrated that integrated HIV care
at the VA can lead to higher rates of viral load suppres-
sion [14]. Given the high, and potentially expanding,
rates of CMS enrollment in the HIV population, an un-
derstanding of Medicare and Medicaid enrollment and
the frequency and drivers of CMS use among veterans
with HIV is necessary to inform efforts to coordinate
care.
The objectives of this paper were to: 1) determine the
frequency of Medicare and/or Medicaid enrollment
among HIV-infected veterans engaged in VA care, com-
pared with uninfected veterans; 2) determine the fre-
quency of non-VA hospital admissions among male,
CMS enrolled HIV-infected and uninfected veterans with
any hospitalizations; and 3) identify characteristics that pre-
dict non-VA hospital admission among male HIV-infected
veterans enrolled in Medicare and/or Medicaid, compared
with uninfected veterans. We hypothesized that CMS en-
rolled HIV-infected veterans would be less likely to use
non-VA care than their uninfected counterparts.
Methods
This retrospective cohort study included two popula-
tions of veterans in VA care in the United States during
2004 and 2005: 1) HIV-infected veterans; and 2) age,
race and facility-matched uninfected comparators.
We used data from the Veterans Aging Cohort Study
(VACS), a prospective, observational cohort study of
HIV infected veterans and age, race and site matched
controls. VACS is made up of eight urban sites, but also
includes a virtual cohort (VACS-VC), a nationally repre-
sentative sample of HIV-infected veterans and matched
uninfected controls identified through the VA electronic
medical record (EMR) system and followed since 1996
[17,18]. Demographic data, medical diagnoses (based onInternational Classification of Diseases, Ninth Revision,
Clinical Modification [ICD-9-CM] codes), and labora-
tory results were extracted from VA EMR. Medicare
and/or Medicaid enrollment and utilization for these
veterans were extracted from data provided by the Cen-
ter for Medicare & Medicaid Services (CMS). The study
received approval from Human Investigations Commit-
tee at Yale University and the VA Connecticut Health-
care System and was granted a waiver of informed
consent.
We started with a cohort that included all veterans en-
rolled in the VACS-VC prior to January 1, 2003 (cohort
1 in Figure 1) and engaged in VA care. For the purpose
of this analysis we defined engaged in care as at least
one inpatient or outpatient visit to a VA medical center
in 2003. Using CMS enrollment data we determined the
frequency of Medicare and/or Medicaid enrollment in
this cohort. To study frequency and drivers of CMS use
we limited our cohort of VA enrolled veterans to include
only those with coverage for CMS use. We narrowed
our sample to veterans that were CMS enrolled in the
2004 and 2005 calendar years and had at least one in-
patient admission in either VA or non-VA hospitals dur-
ing this same period. From this group we excluded those
CMS enrolled for less than 18 months in the 24 month
period, enrolled in HMO plans (as defined in the CMS
data file), and enrolled in Medicaid in more than one
state. Finally, we excluded female veterans, due to their
low numbers in our final sample (cohort 2 in Figure 1).
Our final sample consisted of 7,765 male HIV infected
and uninfected veterans enrolled in FFS Medicare and/
or Medicaid with at least one inpatient admission in
2004 and 2005. We used this cohort to determine the
frequency and predictors of non-VA hospital admissions.
We created a series of variables to identify factors asso-
ciated with non-VA hospital admissions among male vet-
erans, enrolled in fee for service (FFS) Medicare and/or
Medicaid that received inpatient care in 2004 and 2005
(cohort 2). Our dependent variable was a dichotomous in-
dicator of any non-VA admissions, (vs. only VA inpatient
admissions). Hospital admissions were identified by com-
bining VA EMR data with CMS FFS reimbursement files.
We considered a number of independent variables we
believed could influence use of non-VA inpatient care,
including demographics, access to care, illness severity,
and admission to a medical or surgical intensive care
unit (ICU). Age and race data were taken from VA ad-
ministrative databases. Age was constructed as a dichot-
omous variable, under age 65 and 65 years and older.
Race was divided into three categorical variables: White,
African American, and Other.
Patients’ access to care was measured by three variables:
enrollment in Medicare, Medicaid or both programs; dis-
tance to nearest VA tertiary care center treated as a
Figure 1 Cohort development for 2004 dual enrollment and dual use in 2004-2005. 1Veterans Aging Cohort Study Virtual Cohort. 2Veterans
Administration. 34827 veterans excluded because died in 2004 or 2005. 4Health Maintenance Organization. 5Fee-for-service.
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miles, 60-119.9 miles, and greater than 120 miles [19]; and
an indicator of whether veterans were subject to co-pays
for VA care. Co-pay status was in turn determined using
data on service connection, medical conditions, and an
income-based means test for each veteran.
We used the CMS hierarchical condition categories
(HCC) model to calculate risk scores [20] and used the
scores as a measure of patients’ illness severity. The HCC
model is a risk adjustment method employed by CMS to
predict prospective payments for patients based on the pre-
vious year’s claims data, using patient demographics and
major medical conditions, and has been applied to the VA
population in the past for similar analyses [7]. Each year the
average risk score is set at one, and we divided our HCC
risk scores into a dichotomous variable: scores greater than
one and scores less than or equal to one. We created a bin-
ary variable for HIV status, identified through VA admi-
nistrative data. We also used VA administrative data to
identify veterans that carried a diagnosis of a substance use
problem (illicit substance abuse or dependence) using ICD-
9CM codes and a previously validated algorithm available
on the VACS website (vacohort.org).We generated categorical variables for number of in-
patient admissions (one vs. two or more) and the admis-
sion diagnosis (ICU vs. non-ICU admission) because we
believe both could influence the likelihood of a veteran
having a non-VA admission. Veterans with more fre-
quent admissions have more “opportunities” to be hospi-
talized in a non-VA facility. Similarly, patients in critical
condition, requiring admission to ICUs, may be more
likely to be routed to a non-VA hospital. Though these
variables do not reflect patient behavior, they may influ-
ence the likelihood of an admission outside the VA and,
thus, we controlled for these factors in our model.
Analysis
We first examined veterans in the VACS-VC (cohort 1)
to determine the frequency of CMS enrollment among
veterans engaged in care. We stratified our analysis by
age and HIV status, and used student t-tests to compare
the frequency of CMS enrollment between HIV-infected
and uninfected veterans. Next, we described the cohort of
male, veterans enrolled in FFS Medicare and/or Medicaid
with at least one inpatient admission (cohort 2) using the
independent variables listed above. We stratified cohort
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the two sub-populations. Finally, we explored the asso-
ciation between these independent variables and non-
VA hospital admissions using univariate and multivariable
logistic regression. We created a multivariate model that
included all patients in cohort 2, as well as separate
models stratified by HIV status. All analyses were con-
ducted using SAS version 9.2.
Results
Overall, HIV-infected veterans engaged in VA care were
more likely than uninfected veterans to be enrolled in
Medicare and/or Medicaid (38% vs. 33%, p < 0.01)
(Table 1). While HIV-infected veterans under age 65 were
more likely to be CMS enrolled than uninfected veterans,
(36% vs. 29%, p < 0.01), HIV-infected veterans 65 years
and older were less likely to be CMS enrolled (53% vs.
70%, p < 0.01). The majority of CMS enrolled veterans
were enrolled in Medicare, but HIV-infected veterans were
more likely than uninfected veterans to be enrolled in Me-
dicaid, either alone or in combination with Medicare.
Among veterans enrolled in FFS Medicare and/or Me-
dicaid with at least one inpatient admission (cohort 2)
the frequency of HIV-infected veterans with CMS use
was lower than the frequency among uninfected veterans
(48% vs.54%, p < 0.01) (Table 2). Compared to uninfected
veterans, HIV-infected veterans were younger and lived
closer to VA hospitals. A greater proportion of HIV-
infected veterans was also of African American race, had
an HCC score greater than 1 and carried a diagnosis of
substance use problem.Table 1 Medicare and/or Medicaid enrollment among veteran
All patients n (%)
n = 91369
Total Unique in VACS-VC
Medicare Only 20964 (23)
Medicaid Only 5220 (6)
Medicare and Medicaid 5290 (6)
Total Enrolled in CMS2 31474 (34)
Under 65 n = 82835
Medicare Only 16309 (20)
Medicaid Only 5187 (6)
Medicare and Medicaid 4475 (5)
Total Enrolled in CMS 25971 (31)
65 and over n = 8534
Medicare Only 4655 (55)
Medicaid Only 33 (0)
Medicare and Medicaid 815 (10)
Total Enrolled in CMS 5503 (64)
1Veterans Aging Cohort Study – Virtual Cohort.
2Center for Medicare & Medicaid Service.HIV-infected veterans had lower odds of CMS use
than uninfected veterans (OR = 0.78 [95% CI: 0.71, 0.85])
(Table 3). In addition, older veterans and veterans with
higher HCC risk scores had greater odds of CMS use
than their respective younger and healthier counterparts.
Among HIV-infected veterans a substance abuse diagno-
sis was associated with increased non-VA use (OR = 1.34
[95% CI: 1.14, 1.58]). There was not a significant associ-
ation between substance abuse and non-VA use in unin-
fected veterans (OR = 0.91 [95% CI: 0.80, 1.04]).
The association between HIV status and decreased
odds of non-VA use remained in the multivariable model
(OR = 0.76 [95% CI: 0.68, 0.85]); however, there was no
longer an association between higher HCC risk score
and increased non-VA use (Table 4). We posited that
number of admissions, which had the greatest marginal
effect on the multivariate model, was overwhelming the
effects of other variables. When we removed number of
admissions from the adjusted model (analysis not
shown), both higher HCC risk score and African American
race had significant associations with increased non-VA use
(OR = 1.28 [95% CI: 1.13, 1.44] and OR = 1.18 [95% CI:
1.05, 1.33], respectively).
After stratifying by HIV statuses, the predictors of
CMS use were similar in both the HIV-infected and un-
infected models (Table 4).
Discussion
In our sample of veterans engaged in VA care, we found
that HIV-infected veterans were more likely than their
uninfected counterparts to be enrolled in Medicare and/s enrolled in VACS-VC1 in 2004
HIV+ n (%) HIV- n (%) p-value
n = 29909 n = 61460
6461 (22) 14503 (24) <.0001
2203 (7) 3017 (5) <.0001
2618 (9) 2672 (4) <.0001
11282 (38) 20192 (33) <.0001
n = 27193 n = 55642
5334 (20) 10975 (20) 0.7111
2190 (8) 2997 (5) <.0001
2329 (9) 2146 (4) <.0001
9853 (36) 16118 (29) <.0001
n = 2716 n = 5818
1127 (41) 3528 (61) <.0001
13 (0) 20 (0) 0.3497
289 (11) 526 (9) 0.0192
1429 (53) 4074 (70) <.0001
Table 2 CMS1 enrolled veterans with 1 or more inpatient
admissions in 2004 and 2005
All patients
n (%)
HIV+ n (%) HIV- n (%) p-value
n = 7765 n= 2799 n = 4966
DEMOGRAPHICS
Age
<65 6319 (81) 2405 (86) 3914 (79) <.0001
≥65 1446 (19) 394 (14) 1052 (21)
Race
White 3903 (50) 1343 (48) 2560 (52) 0.009
African American 3755 (48) 1413 (50) 2342 (47)
Other 107 (2) 43 (2) 64 (1)
Distance from VA
0-9.9 miles 3253 (42) 1445 (52) 1808 (36) <.0001
10-29.9 miles 1824 (24) 599 (21) 1225 (25)
30-59.9 miles 1270 (16) 393 (14) 877 (18)
60-119.9 miles 1192 (15) 310 (11) 882 (18)
≥120 miles 224 (3) 52 (2) 172 (3)
Co-pay status
No Co-pay 7174 (95) 2592 (96) 4582 (95) 0.0997
Co-pay 352 (5) 112 (4) 240 (5)
ENROLLMENT
Medicare Only 6408 (83) 2088 (74) 4320 (87) <.0001
Medicaid Only 469 (6) 274 (10) 195 (4)






<1 4129 (53) 1040 (37) 3089 (62) <.0001
≥1 3636 (47) 1759 (63) 1877 (38)
INPATIENT ADMISSIONS
Number of Admissions
1 3186 (41) 1091 (39) 2095 (42) 0.0058
≥2 4579 (59) 1708 (61) 2871 (58)
ICU3 Admission
Yes 1637 (21) 575 (21) 1062 (21) 0.3822
No 6128 (79) 2224 (79) 3904 (79)
Substance Abuse
Yes 1958 (25) 828 (30) 1130 (23) <.0001
No 5807 (75) 1971 (70) 3836 (77)
UTILIZATION
VA4 Admissions Only 3757 (48) 1467 (52) 2290 (46) <.0001
Non-VA Admission 4008 (52) 1332 (48) 2676 (54)
1Center for Medicare & Medicaid Serivces.
2Hierarchical Conditional Category Risk Score.
3Intensive Care Unit.
4Veterans Administration.
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infected veterans under age 65 were more likely to be
CMS enrolled, while HIV-infected veterans 65 years and
older were much less likely to be CMS enrolled. Confirm-
ing our initial hypothesis, we also found that male, HIV-
infected veterans enrolled in FFS Medicare and/or Medic-
aid were less likely to have an outside hospitalization. This
was despite the fact that these veterans were generally
sicker, more likely to have multiple admissions, and more
likely to be enrolled in FFS Medicaid – independent risk
factors for greater non-VA use.
We suspect that HIV-infected veterans were less likely
to use non-VA hospitals because they feel more tied to
the VA – possibly due to the integrated care and the dif-
ferent providers they see in VA infectious disease clinics
or the desire for continuity with established caregivers
for what is historically a stigmatized disease. The pre-
scription drug coverage afforded veterans – and the high
costs of antiretroviral therapy - may also play a signifi-
cant role. While every state provides some coverage for
antiretroviral drugs, the coverage varies substantially.
Very few states cover as many of these drugs as are cov-
ered nationally within VA. This conclusion is also sup-
ported from patient self report data in VACS 8 in which
96% of those on ART reported getting all their antiretro-
viral medications through VA [17].
Our findings on frequency of CMS enrollment among
veterans were not completely consistent with previous
literature. Overall, we found lower rates of Medicare en-
rollment, but higher rates of enrollment in Medicaid
[21]. This difference was particularly evident among vet-
erans 65 years and older where Medicare enrollment has
been reported to be greater than 90% [7,21]. This dif-
ference is likely driven primarily by our initial cohort
(cohort 1), which included only patients who were
already engaged in VA care, i.e. were seen at the VA at
least once in the past year. We suspect that veterans
already receiving care at the VA are less likely to seek al-
ternative forms of coverage than all veterans ever en-
rolled in VA care. The difference may also be partially
attributed to the greater share of HIV-infected veterans
in our sample than in previously studied groups. VACS-
VC is a nationally representative sample of HIV-infected
veterans, not all veterans enrolled in VA care. As noted
in the background, HIV-infected veterans differentially
qualify for Medicare coverage, primarily through disabi-
lity [10]. Similarly, we believe that comorbid and socio-
economic factors that contribute to higher rates of
Medicaid enrollment among all persons living with HIV
contributed to the higher rates of Medicaid enrollment
in our sample of veterans. Among HIV infected and un-
infected veterans, some of these changes may also be
partially driven by a change in the population utilizing
VA care since 1999 [8,21], when Shen, et al. reported
Table 3 Characteristics associated with non-VA inpatient admissions in 2004 and 2005, univariate analysis
All patients n (%) p-value HIV+ n (%) p-value HIV- n (%) p-value
DEMOGRAPHICS
Age
<65 Ref Ref Ref
≥65 1.86 (1.65-2.09) <.0001 1.39 (1.12-1.72) 0.0028 2.05 (1.77-2.36) <.0001
Race
White Ref Ref Ref
African American 0.96 (0.87-1.04) 0.3126 1.08 (0.93-1.26) 0.3031 0.90 (0.81-1.01) 0.0696
Other 3.40 (2.13-5.41) <.0001 3.39 (1.70-6.79) 0.0006 3.58 (1.90-6.74) <.0001
Distance from VA
0-9.9 miles Ref Ref Ref
10-29.9 miles 1.30 (1.16-1.46) <.0001 1.16 (0.96-1.40) 0.1297 1.37 (1.19-1.59) <.0001
30-59.9 miles 1.75 (1.54-2.00) <.0001 1.45 (1.16-1.81) 0.0012 1.91 (1.62-2.25) <.0001
60-119.9 miles 2.55 (2.22-2.93) <.0001 1.92 (1.49-2.46) <.0001 2.82 (2.38-3.34) <.0001
≥120 miles 2.41 (1.82-3.20) <.0001 2.95 (1.62-5.37) 0.0004 2.26 (1.63-3.12) <.0001
Co-pay status
No Co-pay Ref Ref Ref
Co-pay 2.58 (2.04-3.27) <.0001 1.92 (1.30-2.84) 0.001 3.01 (2.22-4.08) <.0001
ENROLLMENT
Medicare Ref Ref Ref
Medicaid 1.94 (1.60-2.36) <.0001 2.51 (1.94-3.27) <.0001 1.75 (1.30-2.36) 0.0003
Medicare and Medicaid 2.40 (2.07-2.79) <.0001 2.95 (2.38-3.68) <.0001 2.26 (1.83-2.80) <.0001
HEALTH
HIV
Positive 0.78 (0.71-0.85) <.0001
Negative Ref
HCC Risk Score1
<1 Ref Ref Ref
≥1 1.14 (1.04-1.25) 0.004 1.26 (1.08-1.46) 0.0039 1.21 (1.08-1.36) 0.0014
INPATIENT ADMISSIONS
Number of Admissions
1 Ref Ref Ref
≥2 3.06 (2.79-3.37) <.0001 4.29 (3.64-5.06) <.0001 2.64 (2.35-2.97) <.0001
ICU2 Admission
Yes 2.21 (1.97-2.47) <.0001 2.00 (1.66-2.42) <.0001 2.34 (2.02-2.70) <.0001
No Ref Ref Ref
Substance Abuse
Yes 1.04 (0.94-1.15) 0.4531 1.34 (1.14-1.58) 0.0004 0.91 (0.80-1.04) 0.1549
No Ref Ref Ref
1Hierarchical Conditional Category Risk Score.
2Intensive Care Unit.
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also reflect an evolving perception of VA care or in-
creased Medicare cost sharing.
Our findings regarding predictors of non-VA hospita-
lization among CMS enrolled veterans engaged in VAcare were consistent with previous literature. In general,
these studies have found older age, increased distance to
the VA, greater cost-sharing and worse health to be as-
sociated with non-VA use [7,8,22,23]. Our results con-
firm these findings among HIV-infected veterans, and
Table 4 Characteristics associated with non-VA inpatient admissions in 2004 and 2005, multivariate analysis
All patients n (%) p-value HIV+ n (%) p-value HIV- n (%) p-value
DEMOGRAPHICS
Age
<65 Ref Ref Ref
≥65 1.90 (1.65-2.17) <.0001 1.61 (1.25-2.08) 0.0002 2.00 (1.70-2.35) <.0001
Race
White Ref Ref Ref
African American 1.05 (0.94-1.16) 0.4032 1.02 (0.86-1.22) 0.8293 1.07 (0.94-1.22) 0.3128
Other 3.17 (1.91-5.27) <.0001 3.58 (1.63-7.85) 0.0015 2.98 (1.52-5.83) 0.0015
Distance from VA
0-9.9 miles Ref Ref Ref
10-29.9 miles 1.51 (1.33-1.72) <.0001 1.41 (1.13-1.75) 0.0022 1.59 (1.35-1.86) <.0001
30-59.9 miles 2.08 (1.79-2.41) <.0001 1.78 (1.38-2.30) <.0001 2.25 (1.87-2.70) <.0001
60-119.9 miles 3.42 (2.92-4.01) <.0001 3.06 (2.29-4.09) <.0001 3.62 (2.99-4.37) <.0001
≥120 miles 3.06 (2.23-4.19) <.0001 5.67 (2.90-11.06) <.0001 2.61 (1.83-3.74) <.0001
Co-pay status
No Co-pay Ref Ref Ref
Co-pay 2.66 (2.05-3.46) <.0001 2.61 (1.68-4.05) <.0001 2.76 (1.99-3.84) <.0001
ENROLLMENT
Medicare Ref Ref Ref
Medicaid 2.83 (2.28-3.52) <.0001 2.93 (2.17-3.94) <.0001 2.57 (1.85-3.57) <.0001
Medicare and Medicaid 2.50 (2.11-2.95) <.0001 2.89 (2.27-3.69) <.0001 2.17 (1.72-2.73) <.0001
HEALTH
HIV
Positive 0.76 (0.68-0.85) <.0001
Negative Ref
HCC Risk Score1
<1 Ref Ref Ref
≥1 0.99 (0.89-1.10) 0.8071 0.95 (0.79-1.14) 0.5937 1.01 (0.88-1.15) 0.9127
INPATIENT ADMISSIONS
Number of Admissions
1 Ref Ref Ref
≥2 3.10 (2.79-3.45) <.0001 4.45 (3.69-5.37) <.0001 2.62 (2.30-2.98) <.0001
ICU2 Admission
Yes 1.73 (1.52-1.96) <.0001 1.42 (1.15-1.76) 0.0012 1.94 (1.65-2.27) <.0001
No Ref Ref Ref
Substance Abuse
Yes 1.16 (1.03-1.31) 0.0179 1.28 (1.05-1.55) 0.0138 1.08 (0.92-1.26) 0.3356
No Ref Ref Ref
1Hierarchical Conditional Category Risk Score.
2Intensive Care Unit.
Chang et al. BMC Health Services Research  (2015) 15:27 Page 7 of 9provide guidance to VA care providers on patients that
are more likely to receive non-VA care and thus benefit
from care coordination efforts with outside providers.
Our results should be viewed in light of several limita-
tions – most importantly, our limited access to data onprivate insurance enrollment and utilization in the VA
population. As a result of the lack of claims data for pa-
tients hospitalized under private insurance, some pa-
tients classified as having only VA admissions may
actually have unaccounted for admissions to non-VA
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ance may lead to significantly lower costs for veterans, in-
fluencing their choice of health care setting. The VACS
does collect some survey data on private insurance enroll-
ment. Among veterans in VACS8, 15% of HIV-infected
veterans and 20% of uninfected veterans reported enroll-
ment in private insurance (analysis not shown). Given the
lower rates of supplemental insurance in the HIV-infected
population, we believe our finding that HIV-infected vet-
erans are less likely to have non-VA admissions likely still
holds true. Another limitation is that inpatient admissions
are more likely to be influenced by factors beyond patient
preference. We tried to control for those variables in our
analysis, but using inpatient admissions as our outcome
may limit the conclusions that can be drawn from our re-
sults. We chose inpatient admissions because non-VA in-
patient care places HIV-infected veterans at risk for
adverse events related to poor coordination of care transi-
tions between outside hospitals and VHA HIV clinics;
however, choice in outpatient setting may be a better re-
flection of patient preferences and will be the subject of
future studies. We also did not take into account pathways
to CMS enrollment. Veterans that were enrolled in Medi-
care or Medicaid prior to engagement with the VA system
may be more likely to have non-VA admissions; the op-
posite may be true of veterans that were seeking care with
the VA prior to enrolling with Medicare and/or Medicaid.
In addition, though most HIV infected people with Medi-
care qualify through disability, it is unknown if this is also
true among veterans.
The heterogeneity of Medicare and/or Medicaid from
state to state further limits our ability to generalize the
data. Medicare Advantage plans, i.e. managed care plans
provided by private insurers, are highly variable by de-
sign, and Medicaid benefits and eligibility vary from
state to state. Moreover, to date only 26 of the 50 states
have chosen to accept the ACA provision to expand Me-
dicaid, making comparisons between states more diffi-
cult in the post-ACA era. Finally, our findings are
limited by the age of our data. We restricted our analysis
to 2004 and 2005, the latest years we had complete data
available. However, we believe our analysis uses more re-
cent data than similar studies analyzing CMS enrollment
and CMS use.
Conclusion
Many veterans engaged in care in the VA are also enrolled
in Medicare and/or Medicaid, including a significant pro-
portion of veterans under age 65. Like the general popula-
tion, the rates of CMS enrollment are higher among HIV
infected veterans. However, among veterans enrolled in
both VA and CMS care, HIV-infected veterans have lower
odds of non-VA hospitalization despite having greater ill-
ness severity and more frequent hospitalizations thanuninfected veterans. The VA’s integrated model of care
used to treat HIV/AIDS may explain why HIV-infected
veterans were more likely to seek care within the VA.
The impact of CMS use on veterans with HIV and
other complex medical conditions requires further inves-
tigation. HIV-infected veterans have complicated med-
ical histories and are likely to experience inefficient care
and poor outcomes related to non-VA use. Research that
provides evidence of the cost and health implications of
CMS use may guide the VA in how aggressively to pur-
sue and retain these patients in the VA system.
Future research should also explore why veterans with
HIV were less likely than uninfected veterans to use
non-VA care. If specific aspects of VA’s integrated care
programs for veterans with HIV, such as intensive case
management, are found to contribute to lower likelihood
of non-VA admission, then this would inform strategies
to limit non-VA use among other veteran populations at
high risk from fragmented care, such as veterans with
other major chronic diseases or illnesses.
CMS enrollment is a valuable resource for veterans who
face higher copayments or live long distances from VA
medical centers; however, among some veterans, CMS
enrollment may lead to inefficient care and poor health
outcomes. As health coverage is further expanded efforts
should be made to ensure that additional coverage is
reaching the populations that can benefit the most. The
VA and federal government should shape their policies to
incentivize use of a single health system and develop pro-
cedures to ensure comprehensive exchange of information
between health systems.
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